Drawing for SUPRAX

USPTO serial 99755926

SUPRAX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GOODMAN, WENDY BETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with SUPRAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter D. Weinstein

Peter D. Weinstein ENTRALTA PLLC4500 WILLIAMS DR STE 212 PMB 511Georgetown, TX 78633United States

Goods and services

ClassDescriptionStatusFirst use
010Medical device for ophthalmic use for suprachoroidal delivery systems for administering biologics, gene therapies, and other therapeutic agents to the eye; Single-use and reusable ophthalmic delivery devices; Microneedle-based delivery devices for ophthalmic administration; Structural components and replacement parts for suprachoroidal delivery systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 6, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 28, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 28, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jul 28, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 28, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 15, 2026DOCKASSIGNED TO EXAMINER—
Jul 15, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 28, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 28, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 28, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 10, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 10, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance